Abstract
Objective There is a need to increase the performance and longevity of dental composites and accelerate the translation of novel composites to the market. This study explores artificial intelligence (AI), specifically machine learning (ML), to predict the performance outcomes (POs) of dental composites from their composite attributes (CAs).
Methods An extensive dataset from over 200 publications was built and refined to 233 samples with 17 CAs and 7 POs. Nine ML models were evaluated for PO prediction performance using classified data, and Five ML models were evaluated for PO regression analysis.
Results The KNN model excelled in predicting flexural modulus (FlexMod), Decision Tree model in flexural strength (FlexStr) and volumetric shrinkage (ShrinkV), and Logistic Regression and SVM models in shrinkage stress (ShrinkStr). Receiver operating characteristic area under the curve (ROC AUC) analysis confirmed these results but found that Random Forest was more effective for FlexStr and ShrinkV, suggesting the possibility of Decision Tree overfitting the data. Regression analysis revealed that the Voting Regressor was superior for FlexMod and ShrinkV predictions, while Decision Tree Regression was optimal for FlexStr and ShrinkStr. Feature importance analysis indicated TEGDMA is a key contributor to FlexMod and ShrinkV, BisGMA and UDMA to FlexStr, and depth of cure, degree of monomer-to-polymer conversion, and filler loading to ShrinkStr.
Significance There is a need to conduct a full analysis using multiple ML models because different models predict different POs better, and for a large, comprehensive dataset to train robust AI models to facilitate the prediction and optimization of composite properties and support the development of new dental materials.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
To be determined
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
